The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
The role of IL-6/JAK2/STAT3 signaling pathway in cancers
Open accessAbstract
Interleukin-6 (IL-6) is a pleiotropic cytokine involved in immune regulation. It can activate janus kinase 2 (JAK2)-signal transducer and activator of transcription 3 (STAT3) signaling pathway. As one of the important signal transduction pathways in cells, JAK2/STAT3 signaling pathway plays a critical role in cell proliferation and differentiation by affecting the activation state of downstream effector molecules. The activation of JAK2/STAT3 signaling pathway is involved in tumorigenesis and development. It contributes to the formation of tumor inflammatory microenvironment and is closely related to the occurrence and development of many human tumors. This article focuses on the relationship between IL-6/JAK2/STAT3 signaling pathway and liver cancer, breast cancer, colorectal cancer, gastric cancer, lung cancer, pancreatic cancer and ovarian cancer, hoping to provide references for the research of cancer treatment targeting key molecules in IL-6/JAK2/STAT3 signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Fofaria, N. M., & Srivastava, S. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu233 · Cited by 132
RetractedShen, J., Wang, M., Li, F., Yan, H., & Zhou, J. (2022) · Bioengineered · doi:10.1080/21655979.2021.2016088 · Cited by 8
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139 · cited 2×
“The IL-6 gene encodes the 212 amino acid length IL-6 precursor protein, including a 28-amino acid signal peptide and a 184-amino acid mature segment (42, 43).”
BackgroundZhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Zheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
Targeting STAT3 in Cancer Immunotherapy
Zou, S., Tong, Q., Liu, B., Huang, W., Tian, Y., & Fu, X. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01258-7 · Cited by 1,050
Bollrath, J., Phesse, T. J., von Burstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T., Lundgren-May, T., Canli, Ö., Schwitalla, S., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.002 · Cited by 946
Marotta, L. L. C., Almendro, V., Marusyk, A., Shipitsin, M., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44745 · Cited by 911
STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells
Matsuda, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.15.4261 · Cited by 895
Ronnov-Jessen, L., Petersen, O. W., & Bissell, M. J. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.1.69 · Cited by 793
Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32533 · Cited by 779
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Rokavec, M., Öner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73531 · Cited by 753
Hillmer, E. J., Zhang, H., Li, H. S., & Watowich, S. S. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.05.001 · Cited by 740
IL-6-Induced Homodimerization of gp130 and Associated Activation of a Tyrosine Kinase
Murakami, M., Hibi, M., Nakagawa, N., Nakagawa, T., Yasukawa, K., Yamanishi, K., Taga, T., & Kishimoto, T. (1993) · Science · doi:10.1126/science.8511589 · Cited by 724
Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Ridker, P. M., & Rane, M. (2021) · Circulation Research · doi:10.1161/circresaha.121.319077 · Cited by 691
Gao, S. P., Mark, K. G., Leslie, K., Pao, W., Motoi, N., Gerald, W. L., Travis, W. D., Bornmann, W., Veach, D., Clarkson, B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31871 · Cited by 666
Cancer associated fibroblasts: the dark side of the coin.
Cirri, P., & Chiarugi, P. (2011) · Europe PMC (PubMed Central) · Cited by 654
Constitutive activation of STAT 3 in breast cancer cells: A review
Banerjee, K., & Resat, H. (2016) · International Journal of Cancer · doi:10.1002/ijc.29923 · Cited by 611
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Bromberg, J., & Wang, T. C. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.009 · Cited by 542
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis
Chang, Q., Bournazou, E., Sansone, P., Berishaj, M., Gao, S. P., Daly, L., Wels, J., Theilen, T., Granitto, S., Zhang, X., et al. (2013) · Neoplasia · doi:10.1593/neo.13706 · Cited by 494
Zilberstein, A., Ruggieri, R., Korn, J. H., & Revel, M. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04531.x · Cited by 487
Jinushi, M., Chiba, S., Yoshiyama, H., Masutomi, K., Kinoshita, I., Dosaka-Akita, H., Yagita, H., Takaoka, A., & Tahara, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106645108 · Cited by 479
Li, L., Yu, R., Cai, T., Chen, Z., Lan, M., Zou, T., Wang, B., Wang, Q., Zhao, Y., & Cai, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106939 · Cited by 381
Wu, X., Tao, P., Zhou, Q., Li, J., Yu, Z., Wang, X., Li, J., Li, C., Yan, M., Zhu, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15119 · Cited by 367
Li, W., Zhang, X., Wu, F., Zhou, Y., Bao, Z., Li, H., Zheng, P., & Zhao, S. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2131-y · Cited by 359
Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?
Micke, P., & tman, A. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.07.977 · Cited by 344
MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2
Ding, L., Xu, Y., Zhang, W., Deng, Y., Si, M., Du, Y., Yao, H., Liu, X., Ke, Y., Si, J., et al. (2010) · Cell Research · doi:10.1038/cr.2010.79 · Cited by 341
The role of STAT3 in leading the crosstalk between human cancers and the immune system
Wang, Y., Shen, Y., Wang, S., Shen, Q., & Zhou, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.12.003 · Cited by 340
Pine, S. R., Mechanic, L. E., Enewold, L., Chaturvedi, A. K., Katki, H. A., Zheng, Y.-L., Bowman, E. D., Engels, E. A., Caporaso, N. E., & Harris, C. C. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr216 · Cited by 333
Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth
Wang, H., Lathia, J. D., Wu, Q., Wang, J., Li, Z., Heddleston, J. M., Eyler, C. E., Elderbroom, J., Gallagher, J., Schuschu, J., et al. (2009) · Stem Cells · doi:10.1002/stem.188 · Cited by 333
Heichler, C., Scheibe, K., Schmied, A., Geppert, C. I., Schmid, B., Wirtz, S., Thoma, O.-M., Kramer, V., Waldner, M. J., Büttner, C., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319200 · Cited by 328
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
Song, T. L., Nairismägi, M.-L., Laurensia, Y., Lim, J.-Q., Tan, J., Li, Z.-M., Pang, W.-L., Kizhakeyil, A., Wijaya, G.-C., Huang, D.-C., et al. (2018) · Blood · doi:10.1182/blood-2018-01-829424 · Cited by 326
Colomiere, M., Ward, A. C., Riley, C., Trenerry, M. K., Cameron-Smith, D., Findlay, J., Ackland, L., & Ahmed, N. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604794 · Cited by 320
LIU, R.-Y., ZENG, Y., LEI, Z., WANG, L., YANG, H., LIU, Z., ZHAO, J., & ZHANG, H.-T. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2310 · Cited by 308
Circulating Levels of Inflammatory Cytokines and Risk of Colorectal Adenomas
Kim, S., Keku, T. O., Martin, C., Galanko, J., Woosley, J. T., Schroeder, J. C., Satia, J. A., Halabi, S., & Sandler, R. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2924 · Cited by 298
Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
Bonotto, M., Gerratana, L., Poletto, E., Driol, P., Giangreco, M., Russo, S., Minisini, A. M., Andreetta, C., Mansutti, M., Pisa, F. E., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0002 · Cited by 295
Highlighted STAT3 as a potential drug target for cancer therapy
Lee, H., Jeong, A. J., & Ye, S.-K. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.7.152 · Cited by 295
The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance
Park, S.-Y., Lee, C.-J., Choi, J.-H., Kim, J.-H., Kim, J.-W., Kim, J.-Y., & Nam, J.-S. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1405-7 · Cited by 292
Serum interleukin-6 levels in colorectal cancer patients—a summary of published results
Knüpfer, H., & Preiss, R. (2010) · International Journal of Colorectal Disease · doi:10.1007/s00384-009-0818-8 · Cited by 291
Li, H., Yang, P., Wang, J., Zhang, J., Ma, Q., Jiang, Y., Wu, Y., Han, T., & Xiang, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01223-x · Cited by 273
Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor
Tian, S., Lamb, P., Seidel, H., Stein, R., & Rosen, J. (1994) · Blood · doi:10.1182/blood.v84.6.1760.1760 · Cited by 243
Zhang, X., Hu, F., Li, G., Li, G., Yang, X., Liu, L., Zhang, R., Zhang, B., & Feng, Y. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0176-3 · Cited by 243
The Tumor Microenvironment in Colorectal Carcinogenesis
Peddareddigari, V. G., Wang, D., & DuBois, R. N. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0038-3 · Cited by 237
Thoennissen, N. H., Iwanski, G. B., Doan, N. B., Okamoto, R., Lin, P., Abbassi, S., Song, J. H., Yin, D., Toh, M., Xie, W. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0536 · Cited by 234
Yeh, H.-H., Lai, W.-W., Chen, H. H. W., Liu, H.-S., & Su, W.-C. (2006) · Oncogene · doi:10.1038/sj.onc.1209464 · Cited by 230 · cited 1×
“IL-6 increases in serum and malignant pleural effusion of patients with lung adenocarcinoma (49, 142).”
BackgroundSTAT3 in the systemic inflammation of cancer cachexia
Zimmers, T. A., Fishel, M. L., & Bonetto, A. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2016.02.009 · Cited by 225
JAK2-binding long noncoding RNA promotes breast cancer brain metastasis
Wang, S., Liang, K., Hu, Q., Li, P., Song, J., Yang, Y., Yao, J., Mangala, L. S., Li, C., Yang, W., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91553 · Cited by 223
JAK-STAT Signalling Pathway in Cancer
Brooks, A. J., & Putoczki, T. (2020) · Cancers · doi:10.3390/cancers12071971 · Cited by 189
Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed
den Brok, W. D., Speers, C. H., Gondara, L., Baxter, E., Tyldesley, S. K., & Lohrisch, C. A. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-4080-9 · Cited by 188
Mesenchymal Stem Cells Promote Formation of Colorectal Tumors in Mice
Tsai, K., Yang, S., Lei, Y., Tsai, C., Chen, H., Hsu, C., Chen, L., Wang, H., Miller, S. A., Chiou, S., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.045 · Cited by 175
Liu, C., Lin, J., Hsu, T., Su, K., Li, A. F., Hsu, H., & Hung, S. (2015) · International Journal of Cancer · doi:10.1002/ijc.29033 · Cited by 169
Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells.
Schneider, M. R., Hoeflich, A., Fischer, J. R., Wolf, E., Sordat, B., & Lahm, H. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00401-2 · Cited by 167
Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development
Sgrignani, J., Garofalo, M., Matkovic, M., Merulla, J., Catapano, C. V., & Cavalli, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061591 · Cited by 165
The Role of Interleukins in Colorectal Cancer
Li, J., Huang, L., Zhao, H., Yan, Y., & Lü, J. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.46651 · Cited by 158
Lakshmanan, I., Ponnusamy, M. P., Das, S., Chakraborty, S., Haridas, D., Mukhopadhyay, P., Lele, S. M., & Batra, S. K. (2011) · Oncogene · doi:10.1038/onc.2011.297 · Cited by 156
Gene of the month: Interleukin 6 (IL-6)
Ataie-Kachoie, P., Pourgholami, M. H., Richardson, D. R., & Morris, D. L. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202493 · Cited by 154
Biswas, S., Chytil, A. M., Washington, K., Romero–Gallo, J., Gorska, A. E., Wirth, P. S., Gautam, S., Moses, H. L., & Grady, W. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3255 · Cited by 153
Epidermal growth factor and lipopolysaccharide activate Stat3 transcription factor in mouse liver.
Ruff-Jamison, S., Zhong, Z., Wen, Z., Chen, K., Darnell, J. E., Jr., & Cohen, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31735-0 · Cited by 152
Liu, F., Poursine‐Laurent, J., Wu, H. Y., & Link, D. C. (1997) · Blood · doi:10.1182/blood.v90.7.2583 · Cited by 150
Zhang, C., Xin, H., Zhang, W., Yazaki, P. J., Zhang, Z., Le, K., Li, W., Lee, H., Kwak, L. W., Forman, S. J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.003 · Cited by 148
The HIF target MAFF promotes tumor invasion and metastasis through IL11 and STAT3 signaling
Moon, E. J., Mello, S. S., Li, C. G., Chi, J., Thakkar, K. N., Kirkland, J. G., LaGory, E. L., Lee, I. J., Diep, A. N., Miao, Y. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24631-6 · Cited by 141
Zhao, H., Guo, Y., Li, S., Han, R., Ying, J., Zhu, H., Wang, Y., Yin, L., Han, Y., Sun, L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5578 · Cited by 139
Karsdal, M. A., Hjorth, P., Henriksen, K., Kirkegaard, T., Nielsen, K. L., Lou, H., Delaissé, J., & Foged, N. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303905200 · Cited by 137
Ataie-Kachoie, P., Pourgholami, M. H., & Morris, D. L. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.09.001 · Cited by 128
Augmented gp130‐mediated cytokine signalling accompanies human gastric cancer progression
Cb, J., Judd, L. M., Menheniott, T. R., Kronborg, I., Dow, C., Yeomans, N. D., Boussioutas, A., Robb, L. G., & Giraud, A. (2007) · The Journal of Pathology · doi:10.1002/path.2218 · Cited by 122
IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis
Brooks, G. D., McLeod, L., Alhayyani, S., Miller, A., Russell, P. A., Ferlin, W. G., Rose‐John, S., Ruwanpura, S. M., & Jenkins, B. J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2388 · Cited by 122
Looyenga, B. D., Hutchings, D., Cherni, I., Kingsley, C., Weiss, G. J., & MacKeigan, J. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030820 · Cited by 120
Role of Stromal Myofibroblasts Infiltrating Colon Cancer in Tumor Invasion
Martín, M., Pujuguet, P., & Martin, F. (1996) · Pathology - Research and Practice · doi:10.1016/s0344-0338(96)80093-8 · Cited by 120
Bharadwaj, U., Marin-Muller, C., Li, M., Chen, C., & Yao, Q. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr075 · Cited by 118
Feurino, L. W., Zhang, Y., Bharadwaj, U., Zhang, R., Li, F., Fisher, W. E., Brunicardi, F. C., Chen, C., Yao, Q. C., & Li, M. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.7.4328 · Cited by 115
Interleukin-6: a villain in the drama of pancreatic cancer development and progression
Holmer, R., Goumas, F. A., Waetzig, G. H., Rose‐John, S., & Kalthoff, H. (2014) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(14)60259-9 · Cited by 115
Bai, J., Sui, J., Demirjian, A. N., Vollmer, C. M., Marasco, W. A., & Callery, M. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3502 · Cited by 115
Barrueco, R. R., Yu, J., Saucedo-Cuevas, L. P., Oliván, M., Llobet‐Navàs, D., Putcha, P., Castro, V., Murga-Penas, E., Collazo-Lorduy, A., Castillo-Martín, M., et al. (2015) · Genes & Development · doi:10.1101/gad.262642.115 · Cited by 112
Xiong, H., Du, W., Zhang, Y., Hong, J., Su, W., Tang, J. T., Wang, Y., Lu, R., & Fang, J. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20777 · Cited by 111
CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway
Wang, L., Zhang, F., Cui, J., Chen, L., Chen, Y., & Liu, B. (2018) · Oncology Reports · doi:10.3892/or.2018.6311 · Cited by 106
Li, R., Huang, Y., & Lin, J. (2020) · Nature Communications · doi:10.1038/s41467-019-14065-6 · Cited by 106
Gozgit, J. M., Bebernitz, G. A., Patil, P. B., Ye, M., Parmentier, J. M., Wu, J., Su, N., Wang, T., Ioannidis, S., Davies, A. M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803813200 · Cited by 104
Lin, Y., Jian, Z., Jin, H., Wei, X., Zou, X., Guan, R., & Huang, J. (2020) · Cell Death and Disease · doi:10.1038/s41419-019-2188-7 · Cited by 103
Role of the microbiome in occurrence, development and treatment of pancreatic cancer
Wang, Y., Yang, G., You, L., Yang, J., Feng, M., Qiu, J., Zhao, F., Liu, Y., Cao, Z., Zheng, L., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1103-2 · Cited by 100
Liu, X., Wang, J., Wang, H., Yin, G., Liu, Y., Xiang, L., & Xiang, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.014 · Cited by 98
HUANG, C., Yang, G., Jiang, T., Zhu, G., Li, H., & Qiu, Z. (2011) · Neoplasma · doi:10.4149/neo_2011_05_396 · Cited by 98
Risk factors for pancreatic cancer: underlying mechanisms and potential targets
Kolodecik, T. R., Shugrue, C., Ashat, M., & Thrower, E. C. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2013.00415 · Cited by 97
Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway
Hsu, H., Lin, J.-H., Hsu, T.-W., Su, K., Wang, C.-W., Yang, K., Chiou, S., & Hung, S. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.07.001 · Cited by 95
RBMS1 promotes gastric cancer metastasis through autocrine IL-6/JAK2/STAT3 signaling
Liu, M., Li, H., Zhang, H., Zhou, H., Jiao, T., Feng, M., Na, F., Sun, M., Zhao, M., Xue, L., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04747-3 · Cited by 95
Xiao, J., Gong, Y., Chen, Y., Yu, D., Wang, X., Zhang, X., Dou, Y., Liu, D., Cheng, G., Lu, S., et al. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00428.2016 · Cited by 91
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
Stone, M. L., & Beatty, G. L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.012 · Cited by 90
Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling
Wang, D., Zheng, X., Fu, B., Nian, Z., Qian, Y., Sun, R., Tian, Z., & Wei, H. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.058 · Cited by 89
IL-6 roles – Molecular pathway and clinical implication in pancreatic cancer – A systemic review
Pop, V.-V., Seicean, A., Lupan, I., Samaşcă, G., & Burz, C. C. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.11.010 · Cited by 88
Xie, Q. M., Yang, Z., Huang, X., Zhang, Z., Li, J., Ju, J., Zhang, H., & Ma, J. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0744-3 · Cited by 88
Xiang, Z., Zhou, Z., Song, S., Li, J., Ji, J. F., Yan, R., Wang, J., Cai, W., Hu, W., Zang, L., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01897-0 · Cited by 88
Kim, B., Yi, E. H., & Ye, S. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0795-8 · Cited by 87
Advances in the Discovery of Selective JAK Inhibitors
Menet, C. J., Rompaey, L. V., & Geney, R. (2013) · Progress in medicinal chemistry · doi:10.1016/b978-0-444-62652-3.00004-1 · Cited by 80
Fang, X., Hong, Y., Dai, L., Qian, Y., Zhu, C., Wu, B., & Li, S. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22691 · Cited by 73
Chou, D. B., Sworder, B. J., Bouladoux, N. J., Roy, C. N., Uchida, A. M., Grigg, M. E., Robey, P. G., & Belkaid, Y. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1011527 · Cited by 71
Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
Geethadevi, A., Nair, A., Parashar, D., Ku, Z., Xiong, W., Deng, H., Li, Y., George, J., McAllister, D. M., Sun, Y., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0483 · Cited by 71
Fukushima, N., Koopmann, J., Sato, N., Prasad, N. B., Carvalho, R., Leach, S. D., Hruban, R. H., & Goggins, M. (2005) · Modern Pathology · doi:10.1038/modpathol.3800337 · Cited by 67
Involvement of Interleukin-6 and Androgen Receptor Signaling in Pancreatic Cancer
Okitsu, K., Kanda, T., Imazeki, F., Yonemitsu, Y., Ray, R. B., Chang, C., & Yokosuka, O. (2010) · Genes & Cancer · doi:10.1177/1947601910383417 · Cited by 65
Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates
Coricello, A., Mesiti, F., Lupia, A., Maruca, A., & Alcaro, S. (2020) · Molecules · doi:10.3390/molecules25153321 · Cited by 59
Chae, S. W., Sohn, J. H., Kim, D., Choi, Y. J., Park, Y. L., Kim, K., Cho, Y. H., Pyo, J., & Kim, J. H. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2011.52.3.445 · Cited by 58
DNA methyltransferase 1 is essential for initiation of the colon cancers
Morita, R., Hirohashi, Y., Suzuki, H., et al. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.10.004 · Cited by 57
Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells.
Miyamoto, Y., Hosotani, R., Doi, R., Wada, M., Ida, J., Tsuji, S., Kawaguchi, M., Nakajima, S., Kobayashi, H., Masui, T., et al. (2001) · PubMed · Cited by 56
Zhou, J., Jiang, Y., Zhao, J., Zhang, H., Fu, J., Luo, P., Ma, Y., Zou, D., Gao, H., Hu, J., et al. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00502-y · Cited by 55
Kim, B., Kim, H. S., Kim, S., Haegeman, G., Tsang, B. K., Dhanasekaran, D. N., & Song, Y. S. (2016) · Cancer Research and Treatment · doi:10.4143/crt.2016.175 · Cited by 53
Shi, J., Feng, J., Xie, J., Mei, Z., Shi, T., Wang, S., Du, Y., Yang, G. S., Wu, Y., Cheng, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09020-8 · Cited by 53
Rodriguez, J. A., Huerta‐Yépez, S., Law, I. K. M., Baay-Guzman, G. J., Tirado-Rodríguez, B., Hoffman, J. M., Iliopoulos, D., Hommes, D. W., Verspaget, H. W., Chang, L., et al. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.08.001 · Cited by 50
SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer
Wang, J., Zhou, H. W., Han, Y. K., Liu, X., Wang, M., Wang, X., Yin, G., Xu, L., & Xiang, M. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1184-8 · Cited by 48
IL-6 variant is associated with metastasis in breast cancer patients
Abana, C. O., Bingham, B. S., Cho, J. H., Graves, A. J., Koyama, T., Pilarski, R., Chakravarthy, A. B., & Xia, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181725 · Cited by 47
Cheng, M. S., Liu, P., & Xu, L. X. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2020.111159 · Cited by 46
Overexpression of Pancreatitis-Associated Protein (PAP) in Human Pancreatic Ductal Adenocarcinoma
Xie, M.-J., Motoo, Y., Iovanna, J., Su, S.-B., Ohtsubo, K., Matsubara, F., & Sawabu, N. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1022520212447 · Cited by 45
Stanzani, E., Martínez‐Soler, F., Mateos, T. M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18363 · Cited by 45
Raj, V., Bhadauria, A. S., Singh, A. K., Kumar, U., Rai, A., Keshari, A. K., Kumar, P., Kumar, D., Maity, B., Nath, S., et al. (2018) · Cytokine · doi:10.1016/j.cyto.2018.03.026 · Cited by 45
Targeting of JAK-STAT Signaling in Breast Cancer: Therapeutic Strategies to Overcome Drug Resistance
Tabassum, S., Abbasi, R., Ahmad, N., & Farooqı, A. A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-20301-6_14 · Cited by 44
G-CSF-activated STAT3 enhances production of the chemokine MIP-2 in bone marrow neutrophils
Nguyen-Jackson, H. T., Li, H. S., Zhang, H., Ohashi, E., & Watowich, S. S. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0312126 · Cited by 43
Seavey, M. M., Lu, L. D., Stump, K. L., Wallace, N. H., Hockeimer, W., O’Kane, T. M., Ruggeri, B., & Dobrzański, P. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0951 · Cited by 42
Kim, B. ⁄., & Park, B. (2018) · Oncology Reports · doi:10.3892/or.2018.6232 · Cited by 42
Zhang, K., Che, S., Pan, C., Su, Z., Zheng, S., Yang, S., Zhang, H., Li, W., Wang, W., & Liu, J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13651 · Cited by 42
P16 and P53 Play Distinct Roles in Different Subtypes of Breast Cancer
Shan, M., Zhang, X., Liu, X., Yu, Q., Liu, T., Liu, Y., Ji, W., Zhong, Z., Zhang, Y., Geng, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076408 · Cited by 41
Su, K., Zhao, Q., Bian, A., Wang, C., Cai, Y., & Zhang, Y. (2018) · Europe PMC (PubMed Central) · Cited by 41
Bae, Y. K., Choi, J. E., Kang, S. H., & Lee, S. J. (2015) · Journal of Breast Cancer · doi:10.4048/jbc.2015.18.3.256 · Cited by 40
A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions
Lin, T. E., HuangFu, W., Chao, M., Sung, T.-Y., Chang, C.-D., Chen, Y.-Y., Hsieh, J., Tu, H., Huang, H.-L., Pan, S., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01379 · Cited by 40
Bone marrow-derived myofibroblasts promote colon tumorigenesis through the IL-6/JAK2/STAT3 pathway
Zhu, L., Cheng, X., Ding, Y., Shi, J., Jin, H., Wang, H., Wu, Y., Ye, J., Lu, Y., Wang, T. C., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.017 · Cited by 39
Sun, C., Yang, J., Cheng, H., Shen, W., Jiang, Z., Wu, M., Li, L., Li, W., Chen, T., Rao, X.-W., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152848 · Cited by 39
Tantawy, M. A., El-Sherbeeny, N. A., Helmi, N. M., Alazragi, R. S., Salem, N. A., & Elaidy, S. M. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03736-4 · Cited by 36
(20S) Ginsenoside Rh2 Inhibits STAT3/VEGF Signaling by Targeting Annexin A2
Wang, Y., Chen, C., Zhang, S., Li, Y., & Jin, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179289 · Cited by 36
Dai, B., Yang, Z.-M., Deng, P., Chen, Y.-R., He, Z., Yang, X., Zhang, S., Wu, H., & Ren, Z. (2019) · Journal of Cancer · doi:10.7150/jca.30645 · Cited by 35
JAK2 inhibition for the treatment of hematologic and solid malignancies
Harry, B. L., Eckhardt, S. G., & Jimeno, A. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.677432 · Cited by 33
Singh, A. K., Bhadauria, A. S., Kumar, U., Raj, V., Rai, A., Kumar, P., Keshari, A. K., Kumar, D., Maity, B., Nath, S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24288-0 · Cited by 29
Long non-coding RNA THOR promotes ovarian Cancer cells progression via IL-6/STAT3 pathway
Ge, J., Han, T., Shan, L., Jing, N., Li, Y., & Wang, J. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00672-1 · Cited by 28
Su, C., Zhou, C., Zhou, S., & Xu, J. (2010) · Medical Oncology · doi:10.1007/s12032-010-9645-6 · Cited by 27
Kang, J., Li, M., Luan, P., Jiang, D., Chen, Y., Xu, X., Yu, Q. C., Xu, Y., Su, Q., Peng, W., et al. (2020) · Cell Biology International · doi:10.1002/cbin.11414 · Cited by 27
IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer
Pěnčík, J., Wiebringhaus, R., Susani, M., Čulig, Z., & Kenner, L. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14215 · Cited by 26
Lee, C., Yang, J.-R., Chen, C., Tsai, M., Hung, P.-F., Chen, S.-J., Chiang, S., Han, C. L., & Lin, P. (2019) · Cancers · doi:10.3390/cancers11010063 · Cited by 26
Udhane, V., Maranto, C., Hoang, D. T., Gu, L., Erickson, A. M., Devi, S., Talati, P. G., Banerjee, A., Iczkowski, K. A., Jacobsohn, K. M., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0508 · Cited by 25
Kong, W.-S., Shen, F.-X., Xie, R.-F., Zhou, G., Feng, Y., & Zhou, X. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113848 · Cited by 24
Wang, L., Zhan, X., Shen, X., Li, M., Yang, J., Yu, W., Chen, H., Jin, B., & Mao, Z. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3281-4 · Cited by 23
WANG, B., ZOU, Q., Sun, M., Chen, J., Wang, T., Bai, Y., Chen, Z., Chen, B., & Zhou, M. (2014) · Oncology Reports · doi:10.3892/or.2014.3476 · Cited by 21
Cao, F., Zhang, Q., Chen, W., Han, C., He, Y., Ran, Q., & Yao, S. (2017) · PubMed · Cited by 20
Singh, A. K., Bhadauria, A. S., Kumar, U., Raj, V., Maurya, V., Kumar, D., Maity, B., Prakash, A., De, A., Samanta, A., et al. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.02.029 · Cited by 18
Xh, X., Cj, X., & Shan, H. (2017) · PubMed · Cited by 18
Liu, Q., Ai, B., Kong, X., Wang, X., Qi, Y., Wang, Z., Fang, Y., & Wang, J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107186 · Cited by 13
The fiber metabolite butyrate reduces gp130 by targeting TRAF5 in colorectal cancer cells
Yuan, Y., Li, B., Kuang, Y., Ni, S., Zhuge, A., Yang, J., Lv, L., Gu, S., Ren, Y. X., Li, Y., et al. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01305-9 · Cited by 8
Cited by
The Role of Inflammation in Cancer: Mechanisms of Tumor Initiation, Progression, and Metastasis
Nishida, A., & Andoh, A. (2025) · Cells · doi:10.3390/cells14070488 · Cited by 270
Liu, X., Cai, Y., Zhang, Y., Zhang, H., Tian, S., Gong, Y., Song, Q., Chen, X., Ma, X., Wen, Y., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107526 · Cited by 39
CD109, a master regulator of inflammatory responses
Batal, A., Garousi, S., Finnson, K. W., & Philip, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1505008 · Cited by 21
Metadata
- Authors
- Huang, B., Lang, X., & Li, X.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2022-12-16
- Volume
- 12
- Pages
- 1023177-1023177
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W4313272502
- Cited by
- 479
- References
- 150
- FWCI
- 32.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.